Literature DB >> 34089224

Colorectal cancer screening and surveillance strategy for patients with Diamond Blackfan anemia: Preliminary recommendations from the Diamond Blackfan Anemia Registry.

Jeffrey M Lipton1,2,3, Christine L S Molmenti2,3,4, Maryam Hussain2, Pooja Desai1,3, Maria Florento2, Eva Atsidaftos1,2, Adrianna Vlachos1,2,3.   

Abstract

Diamond Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome characterized by red cell failure, congenital anomalies, poor linear growth, and cancer predisposition. Two previous analyses from the Diamond Blackfan Anemia Registry have quantified DBA as a cancer predisposition syndrome of moderate cancer penetrance. Patients with DBA have a 4.8-fold higher relative risk of developing cancer with an overall cumulative incidence of 13.7% by age 45 years. The two most prevalent solid tumors are colorectal cancer (CRC) and osteogenic sarcoma. Current and evolving data support the institution of cancer screening and surveillance strategies for CRC in DBA.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Diamond Blackfan anemia; cancer screening; cancer surveillance; early onset colorectal cancer

Mesh:

Substances:

Year:  2021        PMID: 34089224     DOI: 10.1002/pbc.28984

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Diamond-Blackfan anemia.

Authors:  Lydie M Da Costa; Isabelle Marie; Thierry M Leblanc
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Variable Clinical Features in a Large Family With Diamond Blackfan Anemia Caused by a Pathogenic Missense Mutation in RPS19.

Authors:  Sarah Cole; Neelam Giri; Blanche P Alter; D Matthew Gianferante
Journal:  Front Genet       Date:  2022-07-18       Impact factor: 4.772

Review 3.  Early Onset Colorectal Cancer: An Emerging Cancer Risk in Patients with Diamond Blackfan Anemia.

Authors:  Jeffrey M Lipton; Christine L S Molmenti; Pooja Desai; Alexander Lipton; Steven R Ellis; Adrianna Vlachos
Journal:  Genes (Basel)       Date:  2021-12-26       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.